This work aims to elucidate the chemical composition of two essential oil (EO) samples obtained from the leaves of Thymus vulgaris L. (Lamiaceae) collected in two regions of Northwestern Algeria (Tlemcen and Mostaganem) and to assess their in vivo acute toxicity and anti-inflammatory activity. Sixty-six compounds could be identified by means of simultaneous GC-FID and GC-MS, accounting for 99.3% of total thyme oil of Mostaganem (EO.TM) and 99.0% of Tlemcen (EO.TT). In both samples, thymol was the major component, amounting to 59.5% (EO.TM) and 67.3% (EO.TT) of the total oil. EO.TT proved to be acutely toxic to mice at a dose of 4500 mg/kg p.o., whereas EO.TM did not show signs of acute toxicity, even at the highest dose tested (5000 mg/kg p.o.). Both EO samples were proven to possess anti-inflammatory activities, significantly reducing carrageenan-induced paw edema in mice (after 6 hours at a dose of 400 mg/kg p.o) at 58.4% for EO.TT and 50.4% for EO.TM, respectively. In conclusion, it could be demonstrated that EOs of T. vulgaris exhibit a considerable in vivo anti-inflammatory activity at non-toxic doses.
Inflammatory processes are non-specific defense mechanisms developed to protect tissues against damage by harmful stimuli, e.g. pathogens, physical damage or chemical irritants, and initiating repair mechanisms [1] . Unfortunately, inflammation is accompanied by various undesirable symptoms, e.g. edema, erythema and pain, alleviated by nonsteroidal anti-inflammatory drugs with well-known gastrointestinal, renal and cardiovascular adverse effects. Thus, there has recently been an increasing interest in highly effective anti-inflammatory agents from natural sources with as little adverse reaction as possible.
Thyme (Thymus vulgaris L., Lamiaceae)is widely used in traditional medicine and phytotherapy [2] . Its essential oil has been proven to possess a great variety of biological properties, including antibacterial [3, 4] , antifungal [5] , anthelmintic [6] , insect repellent [7] , antioxidant [8] and anticancer [4, 9] effects, often attributed to its high yield of phenolic compounds, i.e. thymol and carvacrol. Up to now, only little is known about anti-inflammatory effects of thyme EOs [10] though there is strong evidence that the antioxidant potential of phenols such as thymol are associated with inhibitory effects on inflammatory processes [11] .
In the present study, we aimed at examining the composition of the leaf EOs of T. vulgaris, collected in two regions of Northwestern Algeria, Mostaganem and Tlemcen, and evaluating their in vivo acute oral toxicity and anti-inflammatory properties using the carrageenan-induced paw edema test. To our best knowledge, this is the first time that T. vulgaris EOs from western Algeria have been analyzed.
The EO yields were 2.2% for EO.TM and 4.2% for EO.TT, respectively, determined on dry weight basis, confirming previous results for a T. vulgaris EO from Algeria [12] .The EO compositions, analyzed by simultaneous GC-FID and GC-MS, are presented in Table 1 . In total, 66 volatile compounds could be identified, accounting for 99.3% of EO.TM and 99% of EO.TT. Both samples are dominated by monoterpenes and their oxygenated derivatives, the major component being thymol with 59.5% in EO.TM and 67.3% in EO.TT, respectively, whereas carvacrol was only found in traces in both EOs. Thus, it can be concluded that the analyzed EOs are typical representatives of the T. vulgaris chemotype thymol [13] . In both samples, thymol is accompanied by minor amounts of its biosynthetic precursors [14] , γ-terpinene(8.7% in EO.TM; 10.1% in EO.TT) and p-cymene (5.6% in EO.TM; 6.0%in EO.TT). The present results are in accordance with results of T. vulgaris EOs of the same chemotype [3] . Interestingly, a previous study on Algerian thyme EO [12] revealed an unusually high content of p-cymene (26.4%) compared with thymol (25.6%), which may be explained by differences in plant age and harvesting times [15] .
Concerning the acute toxicity study of T. vulgaris EOs, mortality was observed in 2 out of 3mice 24 hours after testing EO.TT at a dose of 4500 mg/kg. Sedation and dyspnea were also noted during the first hours after treatment with this dose. According to the guidelines [16] , a toxic dose 4500 mg/kg can be concluded for mice. Concerning EO.TM, no mortality was recorded in the mice tested, but sedation was observed during the first hours after treatment with 5000 mg/kg.
The results of the assessment of anti-inflammatory activity by carrageenan-induced paw edema in mice are given in Table 2 and Figure 1 . The edema volume increases progressively depending on hours, reaching its peak in the control group four hours after carrageenan injection. Carrageenan-induced paw edema is a commonly used experimental model of acute inflammation characterized by a biphasic development of edema [17] . The first phase (1 -2 hours) is dependent on mediator release, e.g. histamine, serotonin and bradykinin [17] , whereas the second phase (3 -6 hours) is sustained by the release of prostaglandins, leukotrienes, lysozymes, proteases, NO and by local infiltrationby neutrophils producing free oxygen radicals, e.g. O 2 and OH˙ [18] . This phase is sensitive to the majority of clinically effective antiinflammatory drugs [17] .
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The treatment of mice with the two EOs of T. vulgaris at different doses showed a highly significant decrease of edema (p< 0.001) from four hours compared with the control, whereas the same could already be observed for diclofenac from three hours compared with the control. These results go along with a previous study on commercial thyme EO [10] . A previous study gave evidence that acute inflammation in the mouse paw edema model is -apart from increased oxygen radical formationmediated by NO, produced by endothelial and from six hours additionally inducible nitric oxide synthase, and by PGE 2 [19] , whose precursor is generated by COX-1 [18] .
Essential oil of Algerian Thymus vulgaris
Natural Product Communications Vol. 12 (4) 2017 613 2.87 ± 0.005 3.09 ± 0.006*** 3.16 ± 0.007*** 3.12 ± 0.008*** 2.88 ± 0.016*** 2.60 ± 0.009*** EO.TM 400 mg/kg 2.89 ± 0.012 3.04 ± 0.008*** 3.11 ± 0.007*** 3.04 ± 0.009*** 2.79 ± 0.014*** 2.54 ± 0.011*** EO.TT 100 mg/Kg 2.83 ± 0.008** 3.12 ± 0.01** 3.16 ± 0.009*** 3.10 ± 0.007*** 2.87 ± 0.004*** 2.69 ± 0.008*** The anti-inflammatory activity of T. vulgaris EOs can be mainly attributed to its main compound, thymol. Indeed, previous studies could demonstrate anti-inflammatory properties for this compound [20, 21] . Thymol seems to interfere with the activity of elastase, a marker of inflammatory disease produced by activated neutrophils [22] , and inhibits COX [23] . As already pointed out, the strong antioxidant activity of thymol also contributes to anti-inflammatory activity [24] . Moreover, thyme EO was shown to reduce the secretion of inflammation mediators such as TNF-α, IL-1 and IL-8 [24] . Additionally, minor compounds, like p-cymene and linalool, may also contribute to anti-inflammatory activity: p-cymene was found to block NF-κB and MAPK signaling pathways, thus reducing TNF-α and IL-1β secretion [25] . Linalool inhibits inducible nitric oxide synthase and thus the proinflammatory effects of NO [26] . In conclusion, it could be demonstrated that T. vulgaris EOs from western Algeria possess a considerable anti-inflammatory activity at doses far below toxic concentrations. Essential oil extraction: Dried leaves (100 g) of T. vulgaris were subjected to hydrodistillation for 3 h using a Clevenger-type apparatus. The essential oils were stored at 4°C until tested.
GC-FID and GC-MS analyses:
GC-FID analysis was performed on a Thermo Quest Trace GC equipped with FID using a SE-52 capillary column (50 m × 0.25 mm × 1.0 µm). Helium 5.0 was used as the carrier gas at a flow rate of 1.5 mL/min; the initial oven temperature was programmed at 60°C for 1 min with an increase to 250°C at a rate of 3°C/min. The MS and FID data were simultaneously acquired using a MS-FID splitter consisting of a quartz Y-splitter and a short (ca. 20 cm) 0.1 mm ID fused silica restrictor column as an inlet to the GC-MS interface and a ca. 1 m × 0.25 mm deactivated fused silica column as a transfer line to the FID detector. The injector and detector temperatures were 230°C and 250°C, respectively. EO sample (0.1 µL) was injected neat at a split ratio of 1:100. GC-MS analysis was performed on a Thermo Quest Automass Solo single quadrupole mass spectrometer with interface heating at 250°C, ion-source at 230°C, EI mode at 70 eV, scan range 40-500 amu, scan rate of 0.5 sec and filament 300 µA. Components were identified using ThermoXcalibur 1.2 software by correlating spectra with NIST08, Wiley 8th Ed, Adams [27] , and Mass Finder terpenoids libraries. The retention indices were determined according to [28] . Quantification was achieved using normalized peak area calculations of the FID without relative FID response factors.
Pharmacological tests
Animals: Swiss albino mice of both sexes (weighing 25 -30 g) were purchased from Pasteur Institute (Algiers, Algeria). They were housed in polypropylene cages with free access to standard pellet diet and water ad libitum, and maintained under controlled conditions of temperature (25 ± 2°C) with a 12 h light/dark cycle. The mice were acclimatized to the environment for 2 weeks prior to experimental use. All experimental protocols were prepared and performed based on ethical guidance of the Institutional Animal Ethical Committee.
Preparation of test samples:
The essential oils of T. vulgaris were suspended in a mixture of distilled water and 1% Tween 80 providing a 100 mg/mL solution to be administered orally to the animals [29] . Additional agents including carrageenan (1%) and diclofenac were dissolved in normal saline (0.9%, w/v) prior to use. All the chemicals used in this study were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA).
Acute oral toxicity:
The acute oral toxicity was tested according to OECD GuidelineN°423 [16] . The animals were fasted for 16 h prior to the experiment with ad lib.access to water. The EOs were orally administered to groups of mice (n = 3) at doses of 50, 100, 200, 300, 500, 1000 and 2000 mg/kg, respectively. The control group received only the vehicle. Animals were continuously observed during 2 h after treatments to detect changes in autonomic or behavioral responses and monitored for any mortality for the following 48 h and then for 7 days. If no death occurred in any group, the test was repeated at higher doses (3000, 4000, 4500 and 5000 mg/kg) with a fresh batch of animals (n = 3).
Anti-inflammatory activity:
The anti-inflammatory activity was assessed on the basis of inhibition of paw edema induced by the injection of carrageenan [30] . The mice were fasted for 16 h prior to the experiment with free access to water. They were divided into 8 groups of 6 animals each. Group I (control) received the vehicle (Tween 80, 10mL/kg), Group II (standard) reference drug (diclofenac, 10 mg/kg). Groups III to V received EO.TM at doses of 100, 200 and 400 mg/kg, respectively. The same doses for EO.TT were administered to Groups VI to VIII, respectively. All the treatments were performed by oral administration. 30 min after drug administration; edema was induced by injecting 50 µL carrageenan (1%, w/v) into the sub-plantar region of the right hind paw. Paw thickness (mm) was measured using digital vernier calipers before injection and every 60 min for 6 h after induction of the inflammation [31] . Edema inhibition percentage was calculated as follows:
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where V t is the paw volume after a specific time interval after carrageenan injection and V 0 the paw volume before carrageenan injection.
Statistical analysis:
The results were statistically analyzed with one-way ANOVA followed by Tukey's HSD test, using R software. Values with p< 0.05 were considered statistically significant.
